| scholarly article | Q13442814 |
| P50 | author | Albert Hofman | Q30121906 |
| P2093 | author name string | B Olofsson | |
| I Wiklund | |||
| A Zanchetti | |||
| D Elmfeldt | |||
| H Lithell | |||
| I Skoog | |||
| P Trenkwalder | |||
| A Degl'Innocenti | |||
| P2860 | cites work | Aspects of quality of life in gastrointestinal disease: some methodological issues. | Q53652279 |
| Identifying patient and physician characteristics that affect compliance with antihypertensive medications | Q57282138 | ||
| Assessment of quality-of-life outcomes | Q70989734 | ||
| Warfarin for atrial fibrillation. The patient's perspective | Q71493675 | ||
| The Hypertension Optimal Treatment Study (the HOT Study) | Q72456928 | ||
| Compliance with treatment and the art of medicine | Q74531692 | ||
| Cognitive function and health-related quality of life in elderly patients with hypertension--baseline data from the study on cognition and prognosis in the elderly (SCOPE). | Q30705098 | ||
| On the generalizability of statistical expressions of health related quality of life instrument responsiveness: a data synthesis. | Q32109482 | ||
| Multi-attribute health status classification systems. Health Utilities Index | Q33569094 | ||
| Multi-attribute preference functions. Health Utilities Index | Q33569100 | ||
| Compliance with antihypertensive therapy | Q33697752 | ||
| Measurement of health status. Ascertaining the minimal clinically important difference | Q34515517 | ||
| Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research | Q34531159 | ||
| Candesartan cilexetil: an update of its use in essential hypertension | Q34636660 | ||
| Interpretation of rhinoconjunctivitis quality of life questionnaire data | Q36827687 | ||
| Interpreting treatment effects in randomised trials | Q41729509 | ||
| Study on COgnition and Prognosis in the Elderly (SCOPE). | Q42615433 | ||
| Quality of life on antihypertensive drug therapy: scientific end-point or marketing exercise? | Q43657327 | ||
| The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial | Q44417511 | ||
| Evaluation of three methods of symptom reporting in a clinical trial of felodipine | Q44643585 | ||
| Does lowering the blood pressure improve the mood? Quality-of-life results from the Hypertension Optimal Treatment (HOT) study. | Q50903690 | ||
| Determining a minimal important change in a disease-specific Quality of Life Questionnaire. | Q51136958 | ||
| The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it? | Q53501333 | ||
| Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide. | Q53521068 | ||
| Quality of life questionnaires: does statistically significant = clinically important? | Q53572519 | ||
| Measuring quality of life in children with asthma. | Q53627974 | ||
| Measuring quality of life in the parents of children with asthma. | Q53627976 | ||
| P433 | issue | 4 | |
| P921 | main subject | quality of life | Q13100823 |
| P304 | page(s) | 239-245 | |
| P577 | publication date | 2004-04-01 | |
| P1433 | published in | Journal of Human Hypertension | Q15746469 |
| P1476 | title | Health-related quality of life during treatment of elderly patients with hypertension: results from the Study on COgnition and Prognosis in the Elderly (SCOPE). | |
| P478 | volume | 18 |
| Q35876368 | Aliskiren in hypertension: evidence for its potential therapeutic value |
| Q46542526 | An evaluation of the effects of an angiotensin receptor blocker on health-related quality of life in patients with high-normal blood pressure (prehypertension) in the Trial of Preventing Hypertension (TROPHY). |
| Q38654802 | Blockade of the angiotensin system improves mental health domain of quality of life: A meta-analysis of randomized clinical trials. |
| Q24240206 | Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia |
| Q24246379 | Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia |
| Q35843278 | Calcium Channel Blockers, Progression to Dementia, and Effects on Amyloid Beta Peptide Production |
| Q50951038 | Determinants of health-related quality of life in women with vertebral fractures. |
| Q37092266 | Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment |
| Q48539576 | Evaluation of a cardiovascular health promotion programme offered to low-income women in Korea |
| Q36497543 | Findings and implications of the Study on COgnition and Prognosis in the Elderly (SCOPE) - a review. |
| Q92734243 | Health-related quality of life in blood pressure control and blood lipid-lowering therapies: results from the CHIEF randomized controlled trial |
| Q27687254 | Health-related quality of life in hypertension, chronic kidney disease, and coexistent chronic health conditions |
| Q47556810 | Mental Health-Ill Health Differences in Disease Severity and Its Sociodemographic Biobehavioral Predictors Among Patients With Knee Osteoarthritis. |
| Q61807613 | Personality Traits, Clinical Characteristics, and Health-Related Quality of Life of Patients with Hypertension in a Primary Hospital in Ghana |
| Q39945164 | Predictors of health-related quality of life among low-income midlife women |
| Q48782637 | Psychological well-being outcomes in disease-free survivors of mid-low rectal cancer following curative surgery |
| Q36172474 | Reducing the risk of stroke in elderly patients with hypertension: a critical review of the efficacy of antihypertensive drugs |
| Q58413497 | Relationship of Resting Baroreflex Activity to 24-Hour Blood Pressure and Mood in Healthy People |
| Q46955914 | Rilmenidine--its antihypertensive efficacy, safety and impact on quality of life in perimenopausal women with mild to moderate essential hypertension |
| Q92377672 | The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019) |
| Q42652103 | The cost-effectiveness of candesartan-based antihypertensive treatment for the prevention of nonfatal stroke: results from the Study on COgnition and Prognosis in the Elderly |
| Q60308888 | The influence of quality of life on the level of adherence to therapeutic recommendations among elderly hypertensive patients |
Search more.